Compressed injection pill for oral insulin delivery
8 February 2019 | By European Pharmaceutical Review
A compressed injection pill could be the future alternative to injections of insulin delivery for patients with type 2 diabetes...
List view / Grid view
Insulin
Committee demands answers on rising cost of insulin in the US
1 February 2019 | By Nikki Withers (European Pharmaceutical Review)
Letters have been sent to Eli Lilly, Novo Nordisk and Sanofi asking them to explain the rapidly increasing cost of insulin...
Insulin supply chain transparency needed to prevent price hikes
2 November 2018 | By Iqra Farooq (European Pharmaceutical Review)
The Endocrine Society has reported that increasing costs of insulin means that people are often deciding to forgo necessary treatment...
Specificity in the recombinant factor C test for endotoxin
26 April 2018 | By Kevin L Williams - bioMerieux
Limulus amebocyte lysate (LAL) users, compendial experts and regulators are still orienting themselves to the recombinant factor C (rFC) assay. Changes to compendial standards do not occur overnight and, for now, users willing to change must perform the alternative validation procedure USP .
Is the finger-stick blood test necessary for type 2 diabetes treatment?
16 June 2017 | By Niamh Marriott (European Pharmaceutical Review)
In the first large pragmatic trial of its kind in the United States, results from a study show that checking finger-stick blood sugars may not help diabetes patients who do not use insulin.
Follow: